key: cord-0834592-lxuvya31
authors: Choi, Yangsean; Lee, Min Kyoung
title: Neuroimaging findings of brain MRI and CT in patients with COVID-19: A systematic review and meta-analysis
date: 2020-11-03
journal: Eur J Radiol
DOI: 10.1016/j.ejrad.2020.109393
sha: 9818b0434cab68b692f148e7d5dbc35be937aab6
doc_id: 834592
cord_uid: lxuvya31

Purpose To comprehensively evaluate the incidences of abnormal neuroimaging findings in patients with COVID-19 via a systematic review and meta-analysis. Method PubMed-MEDLINE and EMBASE were searched for original articles reporting imaging findings of the brain in adult patients with COVID-19 between January 1, 2020 and October 9, 2020. Abnormal neuroimaging findings were categorized as (1) cerebral microhemorrhages, (2) acute spontaneous intracranial hemorrhage (ICH), (3) acute to subacute infarcts, and (4) encephalitis or encephalopathy. Pooled incidences of neuroimaging findings were assessed using random-effects modeling. Between-study heterogeneity was explored by using the χ2 statistic for pooled incidences and the inconsistency index I 2. The quality of the studies was evaluated using the Risk of Bias Assessment Tool for Nonrandomized Studies. Subgroup meta-regression analysis was performed to identify potential sources of heterogeneity. Results Twenty-one eligible papers, including 2125 patients, were identified. The pooled incidences of cerebral microhemorrhages, acute spontaneous ICH, acute/subacute infarcts, and encephalitis/encephalopathy were 6.9 % (95 % confidence interval [CI], 4.9 %–8.9 %), 5.4 % (95 % CI, 3.1 %–7.6 %), 24.0 % (95 % CI, 16.1 %–31.8 %), and 3.3 % (95 % CI, 1.9 %–4.7 %), respectively. Substantial heterogeneities were noted for all neuroimaging findings (I 2 = 87 %–97 %). Significant publication biases were present in the pooled incidences. In the subgroup meta-regression analysis, patients with mean or median ages over 65 years showed a significantly lower incidence of encephalitis/encephalopathy (P < 0.001). Furthermore, studies reported that patients in ICU had significantly higher incidences of cerebral microhemorrhages (P < 0.001) and encephalitis/encephalopathy (P < 0.001). Conclusions Considerable incidences of abnormal neuroimaging findings have been reported in patients with COVID-19. Acute to subacute cerebral infarction was the most prevalent neuroimaging finding.

In December 2019, the epidemic of coronavirus disease 2019 (COVID-19)-caused by the severe acute respiratory syndrome virus (SARS-CoV-2)-was first reported in Wuhan, China. The rapid spread of COVID-19 has made it a public health emergency of international concern [1] . As of October 21, over 40 million people were confirmed to be infected with SARS-CoV-2 globally, with over 700,000 confirmed deaths worldwide [2] . While SARS-CoV-2 is mostly known for causing severe respiratory distress, a growing number of neurologic manifestations have been reported [3, 4] .

In one study from Wuhan, China, 28.2% of the patients with COVID-19 showed an altered mental status or acute cerebrovascular disease [3] . Also, in patients who recovered from COVID-19, neurologic symptoms were reported to be present in 55% of the patients [5] .

Studies (RoBANS) [7] .

The primary outcomes of this meta-analysis were the pooled incidences of abnormal neuroimaging findings, including cerebral microhemorrhages, acute/subacute infarcts, acute spontaneous ICH, and encephalitis/encephalopathy. Meta-analytic pooling was performed using the inverse variance method to calculate weights. Pooled incidences with 95% confidence intervals (CIs) were obtained using Der Simonian-Laird random-effects modeling [19] . Subgroup meta-regression analysis was performed based on patients' mean/median age (>65 or ≤65 years), imaging modality (MRI or CT/MRI), origin of publication (Europe, USA, or Asia), single/multi-center design, indication for imaging (neurologic symptoms or others), and patients in ICU (reported or not reported). Likelihood ratio tests were used to compare the random-effects models in subgroup analysis.

Between-study heterogeneity was calculated by using the χ 2 statistics for pooled estimates (P < 0.05, indicating significant heterogeneity) and the Higgin's inconsistency index (I 2 ), where I 2 values of 0%-40%, 30%-60%, 50%-90%, and 75%-100% indicated insignificant, moderate, substantial, and considerable heterogeneity, respectively [8] . Publication bias was evaluated using funnel plots and Egger's test, with a P-value < 0.1 indicating significant bias [20] .

Publication bias-adjusted pooled incidences were also calculated via the trim-and-fill method [21] , where agreement between the unadjusted and adjusted pooled incidences and estimates may indicate little publication bias. All statistical meta-analyses were performed using R (v.3.6.1, R Foundation for Statistical Computing, Vienna, Austria). A P-value of <0.05 was considered statistically significant.

An overview of the selection process for studies from the literature search is depicted in Figure 1 . The initial literature search identified 231 articles. After the removal of duplicates, 183 articles were screened for eligibility. Among these, 164 were excluded after reviewing their titles and abstracts (84 case reports/series, 50 review/letters/editorials, 28 articles with irrelevant content, 1 non-English J o u r n a l P r e -p r o o f article, and 1 non-human study). The full texts of the remaining 19 articles were thoroughly reviewed; five articles were further excluded due to lack of neuroimaging findings [22, 23] , partially overlapping patient cohorts [24] , high risks of bias based on the quality assessment [25] , and not in the field of interest [26] . Between the two studies with overlapping cohorts, the study with a more recent study period was chosen. An updated literature search for studies published between July 30, 2020 and October 9, 2020 resulted in 346 studies, of which seven studies met the same eligibility criteria [27] [28] [29] [30] [31] [32] [33] . Overall, 21 articles with a total of 2125 patients were included [4, [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . No additional eligible study was found after a search of references within the included studies.

The characteristics of the 21 included studies are summarized in Table 1 . Of the 21 studies, all study designs were retrospective, except for two prospective studies [28, 39] . Nine studies were multi-center studies [4, 29, 31, 33, 36, 38, 40, 42, 43] whereas the other 12 were performed at single centers [27, 28, 30, 32, 34, 35, 37, 39, 41, [44] [45] [46] . The cohort sizes ranged from 9-454 patients. The countries of origin of the selected studies were heterogeneous, including China [40] , Turkey [42] , Europe [4, 30, 35-37, 39, 41, 43, 45, 46] , and the USA [27, 28, 31-34, 38, 44] . One study was a multinational study involving all three continents [29] . Brain MRI was the only neuroimaging modality used in ten of the studies [4, 28, 32, 33, 37, 39, [41] [42] [43] [44] whereas ten studies used brain CT and/or MRI [27, 29-31, 34-36, 38, 45, 46] ; one study used only brain CT [40] .

In the included studies, 42.6% (906/2125) of the patients showed abnormal neuroimaging findings on brain CT or MRI. The pooled incidence of cerebral microhemorrhages in 20 studies (excluding one study that used brain CT alone [40] ) was 6.9% (95% CI: 4.9%-13.8%; I 2 = 94%) [ Table 2 and Fig.   3(a) ]. The pooled incidence of acute spontaneous ICH in the included studies (n = 21) was 5.4% (95% CI: 3.1%-7.6%; I 2 = 87%) [ Table 2 and Fig. 3(b) ]. In 20 studies (excluding one study that excluded patients with infarction) [47] , the pooled incidence of acute to subacute infarct was 24.0% (95% CI:

16.1%-31.8%; I 2 = 97%) [ Table 2 and Fig. 3(c) ]. The pooled incidence of encephalitis or J o u r n a l P r e -p r o o f encephalopathy was 3.3% (95% CI: 1.9%-4.7%; I 2 = 92%) [ Table 2 and Fig. 3(d) ].

All four types of abnormal neuroimaging findings demonstrated significant publication bias on funnel plots (i.e., asymmetric distribution of studies) (Fig. 4 ) and in Egger's tests (P < 0.05). Moreover, except for the acute/subacute infarct category, the trim-and-fill estimates were inconsistent with the pooled incidences, indicating publication bias ( Table 2 ). All included studies had significant betweenstudy heterogeneities (P< 0.001).

The results of the subgroup meta-regression analysis are summarized in Table 3 . In the subgroup analysis of cerebral microhemorrhages, studies using only MRI demonstrated significantly higher incidences (13.8%) than those using either CT or MRI (3.1%) (P < 0.001). Regionally, studies published in Europe showed higher pooled incidences of cerebral microhemorrhages (14.0%) than those in the USA (4.1%) or Asia (3.0%) (P < 0.001). Moreover, studies that reported patients in ICU showed higher pooled incidences (11.8%) than those not reporting patients in ICU (3.2%) (P < 0.001).

For the incidence of encephalitis/encephalopathy, imaging modality (MRI, 6.9% vs. CT/MRI, 2.1%; P < 0.001), region (Europe, 12.9% vs. USA, 1.8% and Asia, 2.6%; P <0.001), median/mean age (>65 years, 1.7% vs. ≤65 years, 10.5%; P < 0.001), and patients in ICU (11.1% vs. not reported, 0.7%; P < 0.001) demonstrated significant differences.

While considerable heterogeneities remained in most subgroup analyses, little heterogeneity was observed in encephalitis/encephalopathy for older patients (I 2 = 8%).

The quality assessment, according to RoBANS, indicated moderate overall quality, with all studies satisfying at least three of the six criteria (Fig. 2) . Notably, for the "selection of participants" domain, none of the studies confirmed neuroimaging findings among the study participants at study initiation.

In the present meta-analysis evaluating the pooled incidences of abnormal neuroimaging findings in J o u r n a l P r e -p r o o f patients with COVID-19, acute to subacute infarcts were the most common [24.0%, 95% CI = 16.1%-31.8%], followed by cerebral microhemorrhages [6.9%, 95% CI = 4.9%-8.9%], acute spontaneous intracerebral hemorrhages [5.4%, 95% CI = 3.1%-7.6%], and encephalitis/encephalopathy [3.3%, 95% CI = 1.9%-4.7%]. Substantial heterogeneities were observed across studies, and subgroup analysis did not reveal specific sources of potential heterogeneity. Substantial publication biases were present among all types of imaging findings. These results add evidence for the considerable incidence of abnormal neuroimaging findings in patients with COVID-19. Therefore, our results may increase the awareness of COVID-19-related neuroimaging findings among radiologists. [48] . They found that the most common symptoms were smell and taste disorders and headaches, indicating the involvement of the central nervous system. The difference between their study and the present study was that their study consisted of many case reports/series without neuroimaging findings, and meta-analytic assessment was not available. The current study attempted to focus on specific COVID-19-related neuroimaging findings with meta-analytic outcomes.

As for the possible pathogeneses underlying various neuroimaging findings, the severe coagulopathy often present in COVID-19 patients might be responsible for the relatively common incidence of disseminated cerebral microhemorrhages [49] -as a milder form of acute spontaneous ICH. However, a study by Radmanesh et al. showed that among seven critically ill COVID-19 patients with cerebral microhemorrhages, none showed overt disseminated intravascular coagulation [44] . They postulated that cerebral microhemorrhages could be a late complication of critical-stage COVID-19 related to hypoxemia or a form of small vessel vasculitis. Therefore, the underlying mechanism of the development of cerebral microhemorrhages remains to be elucidated.

Patients with encephalitis and encephalopathy were grouped since their imaging patterns were often non-specific, including leptomeningeal enhancement [43] , acute hemorrhagic necrotizing encephalopathy [44] , diffuse leukoencephalopathy [44] , and increased white matter signal intensities after accounting for age [34] , ADEM, and PRES [39, 41, 45] . These manifestations suggest that SARS-CoV-2 causes acute brain injury via unexplained mechanisms. Although these aspects are not were under mechanical ventilation. Furthermore, the mean and median patients ages in all included studies were over 58 years, indicating that the patients belonged to older age groups that are more vulnerable to severe disease [47] . Therefore, such predispositions would make the patients included in this study more susceptible to developing abnormal neuroimaging findings.

Several limitations need to be addressed. First, the literature search period was limited to several months; however, due to the ever-increasing concerns on the spread of COVID-19 globally, rapid collation of available evidence is needed to understand the various COVID-19-associated neuroimaging findings. Additionally, in most selected studies, confounding variables such as underlying comorbidities were not statistically adjusted for the neuroimaging findings, nor were there control groups. Again, considering the urgency of the COVID-19 pandemic, a careful review of patients' medical records must have been difficult. Moreover, the causal relationship between J o u r n a l P r e -p r o o f COVID-19 infection and abnormalities in imaging findings is not fully established; abnormal neuroimaging findings might be due to systematic confounding factors such as DM, mechanical ventilation, and the multi-drug regimen for respiratory distress with hypoxia. Finally, nearly all the diagnoses of encephalitis and encephalopathy were not definite without serologic confirmation. These limitations necessitate a future prospective study with adjustment for comorbidities and a more detailed analysis to confirm the association between COVID-19 and neuroimaging findings.

In conclusion, the current systematic review and meta-analysis demonstrated a considerable incidence of abnormal neuroimaging findings related to COVID-19. The findings of this study may help increase awareness of the wide range of COVID-19-related neuroimaging findings among radiologists worldwide. J o u r n a l P r e -p r o o f 

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Neurologic manifestations of hospitalized patients with coronavirus disease

Neurologic features in severe SARS-COV-2 infection

Cerebral Micro-Structural Changes in COVID-19 Patients-An MRI-based 3-month Follow-up Study

Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features

Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report

Cochrane handbook for systematic reviews of interventions

COVID-19-associated meningoencephalitis complicated with intracranial hemorrhage: a case report

Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection

Posterior reversible encephalopathy syndrome

Another imaging manifestation of COVID-19

Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology

COVID-19-associated acute disseminated encephalomyelitis (ADEM)

First case of Covid-19 presented with cerebral venous thrombosis: A rare and dreaded case

COVID-19-associated acute cerebral venous thrombosis: Clinical, CT, MRI and EEG features

A Case of Coronavirus Disease 2019 With Concomitant Acute Cerebral Infarction and Deep Vein Thrombosis

Cerebrovascular Disease in COVID-19

Meta-analysis in clinical trials

Bias in meta-analysis detected by a simple, graphical test

Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study

Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience

Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic

Clinical and Neuroimaging Correlation in Patients with COVID-19

Assessment of Brain Injury Using Portable, Low-Field Magnetic Resonance Imaging at the Bedside of Critically Ill Patients

Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study

COVID-19-related intracranial imaging findings: a large single-centre experience

Patients with COVID-19: Findings at an Academic Institution during the Height of the Outbreak

COVID-19-Related Disseminated Leukoencephalopathy (CRDL): A Retrospective Study of Findings on Brain MRI

Cerebral Microbleeds and Leukoencephalopathy in Critically Ill Patients With COVID-19

Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States

Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings

Unusual Microbleeds in Brain MRI of Covid-19 Patients

COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome

Early postmortem brain MRI findings in COVID-19 non-survivors

New onset neurologic events in people with COVID-19 infection in three regions in China

Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations

Brain MRI Findings in Patients in the Intensive Care Unit with COVID-19 Infection

Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study

COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages

Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes

Nervous System Involvement in COVID-19: Results from a Retrospective Consecutive Neuroimaging Cohort

Update on neurological manifestations of COVID-19

Neurological manifestations of COVID-19: A systematic review

Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain

The authors declare no acknowledgement.J o u r n a l P r e -p r o o f